Development of controlled, targeted drug delivery systems represents one of the frontier areas of biomaterials science, where a multidisciplinary approach is of direct benefit to human healthcare. We demonstrate herein the potential of sol–gel derived phosphate-based glass for use in drug delivery applications. Our low-temperature sol–gel synthesis of phosphate-based glasses has made it possible to incorporate relatively unstable functional molecules for controlled release. We demonstrate the potential of this approach by incorporating the chemotherapy agent cisplatin in a CaO–Na2O–P2O5 glass. X-ray absorption spectroscopy is used to show that the chlorine ligands of cisplatin undergo exchange with oxygen during the synthesis, consistent with binding to the phosphate groups of the sol–gel. UV–visible spectroscopy reveals the subsequent release of cisplatin into an aqueous medium.
TorchilinV.P.Structure and Design of Polymeric Surfactant-based Drug Delivery Systems, J. Control. Release, 2001: 73: 137–172.
2.
KataokaK.HaradaA.NagasakiY.Block Copolymer Micelles for Drug Delivery: Design, Characterization and Biological Significance, Adv. Drug Deliv. Rev., 2001: 47: 113–131.
3.
AndresenT.L.JensenS.S.JorgensenK.Advanced Strategies in Liposomal Cancer Therapy: Problems and Prospects of Active and Tumor Specific Drug Release, Prog. Lipid Res., 2005: 44: 68–97.
4.
GuptaP.VermaniK.GargS.Hydrogels: from Controlled Release to pH-responsive Drug Delivery, Drug Discov. Today, 2002: 7: 569–579.
5.
PanyamJ.LabhasetwarV.Biodegradable Nanoparticles for Drug and Gene Delivery to Cells and Tissue, Adv. Drug Deliv. Rev., 2003: 55: 329–347.
6.
KumarM.A Review of Chitin and Chitosan Applications, React. Funct. Polym., 2000: 46: 1–27.
7.
ChengK.PengS.XuC.J.SunS.H.Porous Hollow Fe3O4 Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin, J. Am. Chem. Soc., 2009: 131: 10637–10644.
8.
GuptaA.K.GuptaM.Synthesis and Surface Engineering of Iron Oxide Nanoparticles for Biomedical Applications, Biomaterials, 2005: 26: 3995–4021.
9.
FeazellR.P.Nakayama-RatchfordN.DaiH.LippardS.J.Soluble Single-walled Carbon Nanotubes as Longboat Delivery Systems for Platinum (IV) Anticancer Drug Design, J. Am. Chem. Soc., 2007: 129: 8438–8439.
10.
LiW.G.AiH.ChenW.L.JiangL.J.WuX.Z.Cellular Toxic Effects of Combination of Low Dose of Cisplatin and Interstitial Injection of P-32 Glass Microspheres on Mouse Solid Tumor S180, Chin. Med. J. (Engl.), 2005: 118: 1099–1104.
11.
CummingsJ.Microspheres as a Drug Delivery System in Cancer Therapy, Expert Opin. Ther. Pat., 1998: 8: 153–171.
12.
DiamandidouE.AjaniJ.A.YangD.J.. Two-phase Study of Hepatic Artery Vascular Occlusion with Microencapsulated Cisplatin in Patients with Liver Metastases from Neuroendocrine Tumors, Am. J. Roentgenol., 1998: 170: 339–344.
13.
PasquaL.TestaF.AielloR.CundariS.NagyJ.B.Preparation of Bifunctional Hybrid Mesoporous Silica Potentially Useful for Drug Targeting, Microporous Mesoporous Mater., 2007: 103: 166–173.
14.
PankhurstQ.A.ConnollyJ.JonesS.K.DobsonJ.Applications of Magnetic Nanoparticles in Biomedicine, J. Phys. D., 2003: 36: R167–R181.
DriverP.M.TelferS.B.An Assessment of the Performance of a New Formulation of Soluble Phosphate-Glass Bolus on the Copper and Selenium Status of Scottish Blackface Ewes, Anim. Prod., 1988: 46: 491.
17.
GilchristT.HealyD.M.DrakeC.Controlled Silver-releasing Polymers and their Potential for Urinary-tract Infection Control, Biomaterials, 1991: 12: 76–78.
18.
BitarM.SalihV.MuderaV.KnowlesJ.C.LewisM.P.Soluble Phosphate Glasses: In Vitro Studies Using Human Cells of Hard and Soft Tissue Origin, Biomaterials, 2004: 25: 2283–2292.
19.
KnowlesJ.C.Phosphate Based Glasses for Biomedical Applications, J. Mater. Chem., 2003: 13: 2395–2401.
20.
MatsumotoA.MatsukawaY.SuzukiT.YoshinoH.Drug Release Characteristics of Multi-reservoir Type Microspheres with Poly(DL-lactide-co-glycolide) and Poly(DL-lactide), J. Control. Release, 2005: 106: 172–180.
21.
LoehrerP.J.EinhornL.H.Drugs 5 Years Later – Cisplatin, Ann. Intern. Med., 1984: 100: 704–713.
22.
PickupD.M.GuerryP.MossR.M.KnowlesJ.C.SmithM.E.NewportR.J.New Sol-Gel Synthesis of a (CaO)0.3(Na2O)0.2(P2O5)0.5 Bioresorbable Glass and its Structural Characterisation, J. Mater. Chem., 2007: 17: 4777–4784.
23.
PickupD.M.ValappilS.P.MossR.M.. Preparation, Structural Characterisation and Antibacterial Properties of Ga-doped Sol-Gel Phosphate-based Glass, J. Mater. Sci., 2009: 44: 1858–1867.
HincalA.A.LongD.F.ReptaA.J.Cisplatin Stability in Aqueous Parenteral Vehicles, J. Parenter. Drug Assoc., 1979: 33: 107–116.
26.
CurisE.ProvostK.NicolisI.. Carboplatin Decomposition in Aqueous Solution with Chloride Ions Monitored by X-ray Absorption Spectroscopy, New J. Chem., 2000: 24: 1003–1008.
27.
SegalE.LepecqJ.B.Role of Ligand-exchange Processes in the Reaction-kinetics of the Antitumor Drug Cis-Diamminedichloroplatinum(II) with its Targets, Cancer Res., 1985: 45: 492–498.
28.
BarrougA.KuhnL.T.GerstenfeldL.C.GlimcherM.J.Interactions of Cisplatin with Calcium Phosphate Nanoparticles: In Vitro Controlled Adsorption and Release, J. Orthop. Res., 2004: 22: 703–708.
29.
CzarnobajK.LukasiakJ.In Vitro Release of Cisplatin from Sol-Gel Processed Porous Silica Xerogels, Drug Deliv., 2004: 11: 341–344.
30.
CzarnobajK.LukasiakJ.In Vitro Release of Cisplatin from Sol-Gel Processed Organically Modified Silica Xerogels, J. Mater. Sci.: Mater. Med., 2007: 18: 2041–2044.
31.
JakupecM.A.KepplerB.K.Gallium in Cancer Treatment, Curr. Top. Med. Chem., 2004: 4: 1575–1583.
